middle.news
Artrya Raises A$15M to Accelerate Salix® Coronary Software US Rollout
7:59am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Artrya Raises A$15M to Accelerate Salix® Coronary Software US Rollout
7:59am on Monday 2nd of June, 2025 AEST
Key Points
A$15 million placement at A$0.73 per share with a 10.4% discount
Funds to accelerate FDA regulatory applications for Salix® Coronary Plaque and Flow products
Initiation of the flagship SAPPHIRE study to boost clinical credibility and US hospital adoption
Tranche two placement subject to shareholder approval in April 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Artrya (ASX:AYA)
OPEN ARTICLE